Schedule 13G ownership disclosure

Perspective Therapeutics Inc

Common Stock, $0.001 par value · CUSIP: 46489V302

Event date: 2026-02-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Avidity Partners Management LP

    Shares: 6,049,999.00 · Class: 5.3%

  • Avidity Partners Management (GP) LLC

    Shares: 6,049,999.00 · Class: 5.3%

  • Avidity Capital Partners Fund (GP) LP

    Shares: 6,049,999.00 · Class: 5.3%

  • Avidity Capital Partners (GP) LLC

    Shares: 6,049,999.00 · Class: 5.3%

  • Avidity Private Master Fund I LP

    Shares: 5,849,999.00 · Class: 5.1%

  • Michael Gregory

    Shares: 6,049,999.00 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-26-001548
Form type
SCHEDULE 13G
Filer
Avidity Partners Management LP
CIK
CIK 1791827
Filed
Mar 10, 2026
Reporting period
Feb 20, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub